Obesity Surgery

, Volume 22, Issue 10, pp 1629–1632

Efficacy of Laparoscopic Greater Curvature Plication for Weight Loss and Type 2 Diabetes: 1-Year Follow-Up

Clinical Research



Laparoscopic greater curvature plication (LGCP) has gained popularity within the last 2 years because it is a restrictive procedure that reduces gastric volume without the need for stomach resection.


A prospective study was performed in which 55 morbidly obese patients with type 2 diabetes (44 female, 11 male) underwent LGCP. The patients had a mean age of 38.5 years (22–55 years), mean BMI of 43.5 kg/m2 (35–52 kg/m2), and mean glycosylated hemoglobin (HbA1c) of 7.9 % (6–10 %).


All procedures were completed laparoscopically. The mean operative time was 55 min (40–80 min), and the mean hospital stay was 1.8 days (1.5–5 days). No intraoperative or postoperative complications were reported apart from three cases of resistant nausea and vomiting and one case of intraluminal bleeding. The mean excess weight loss (EWL%) was 35 % (30–65 %) after 12 months with a mean BMI of 38 kg/m2 after 12 months. A total of 23 % of patients stopped losing weight 6 months after the procedure, and 11 % began regaining about 14 % (12–20 %) of their EWL 9 months after the procedure. The mean HbA1c was 7.5 % (5.5–8 %) after 12 months.


LGCP is feasible and safe in the short term when applied to morbidly obese patients, but may be unsustainable. It is inferior as a restrictive procedure for resolution of type 2 diabetes. Longer follow-up and prospective comparative trials are needed to clarify whether it can be considered an effective single-stage procedure for treating morbidly obese diabetic patients and their comorbidities.


Plication Diabetes Laparoscopic Bariatric Surgery 


  1. 1.
    Tsigosa C, Hainer V, Basdevant A, et al. Management of obesity in adults: European Clinical Practice Guidelines. Eur J Obes. 2008;2:106–16. PMID 20054170.Google Scholar
  2. 2.
    Wing R, Phelan S (2004) Science-based solutions to obesity: what are the roles of academia, government, industry, and health care? Proceedings of a Symposium, Boston, Massachusetts, USA, 10–11 March 2004 and Anaheim, California, USA, 2 October 2004Google Scholar
  3. 3.
    Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194–9. PMID 18006966.PubMedCrossRefGoogle Scholar
  4. 4.
    Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 1981;116(5):602–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg. 2011;21(11):1657–63.PubMedCrossRefGoogle Scholar
  6. 6.
    Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A. 2007;17(6):793–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Sales Puccini CE. Surset gلstrico de Sales: una alternative para cirugيa bariلtrica restrictive. Rev Colomb Cir. 2008;23(3):131–5.Google Scholar
  8. 8.
    Brethauer SA, Harris JL, Chand B, et al. Initial results of vertical gastric plication for severe obesity. Phoenix: Society of American Gastrointestinal and Endoscopic Surgeons; 2009.Google Scholar
  9. 9.
    (1992) Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 55(2 Suppl):615S–9SGoogle Scholar
  10. 10.
    DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.PubMedCrossRefGoogle Scholar
  11. 11.
    O'Brien PE. Laparoscopic adjustable gastric banding: a real option for a real problem. ANZ J Surg. 2003;73(8):562.PubMedCrossRefGoogle Scholar
  12. 12.
    Gumbs AA, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17(7):962–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Ramos A, Galvao Neto M, Galvao M, et al. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. Obes Surg. 2010;20:913–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16(9):1138–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Campos JM, Siqueira LT, Meira MR, et al. Gastrobronchial fistula as a rare complication of gastroplasty for obesity: a report of two cases. J Bras Pneumol. 2007;33(4):475–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:S290–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2012

Authors and Affiliations

  1. 1.Assiut UniversityAssiutEgypt
  2. 2.Assiut University HospitalAssiutEgypt
  3. 3.Plastic Surgery DepartmentAssiut University HospitalAssiutEgypt

Personalised recommendations